This inventor holds 9 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1988-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokushima, JP (1988 - 2012)
- Naruto, JP (2002 - 2013)
Company Filing History:
Years Active: 1988-2013
Title: Chikamasa Yamashita: Innovator in Dry Powder Inhalation Systems
Introduction
Chikamasa Yamashita is a prominent inventor based in Naruto, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of dry powder inhalation systems. With a total of 9 patents to his name, Yamashita's work has the potential to enhance the delivery of medications through innovative inhalation methods.
Latest Patents
Yamashita's latest patents include a dry powder inhalation system designed for transpulmonary administration. This system is characterized by its unique combination of features that optimize the inhalation process. The invention aims to provide a novel approach to delivering medications effectively through the lungs, thereby improving patient outcomes.
Career Highlights
Chikamasa Yamashita is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the field of inhalation technology. His work at Otsuka has allowed him to collaborate with other experts in the industry, further advancing the development of effective pharmaceutical solutions.
Collaborations
Yamashita has worked alongside notable colleagues such as Akitsuna Akagi and Shigeru Ibaragi. These collaborations have played a crucial role in the refinement and success of his inventions, showcasing the importance of teamwork in the field of innovation.
Conclusion
Chikamasa Yamashita's contributions to dry powder inhalation systems highlight his dedication to improving pharmaceutical delivery methods. His innovative spirit and collaborative efforts continue to pave the way for advancements in healthcare technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile